690 related articles for article (PubMed ID: 12975269)
1. Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.
Vissink A; Kalk WW; Mansour K; Spijkervet FK; Bootsma H; Roodenburg JL; Kallenberg CG; Nieuw Amerongen AV
Arch Otolaryngol Head Neck Surg; 2003 Sep; 129(9):966-71. PubMed ID: 12975269
[TBL] [Abstract][Full Text] [Related]
2. Oral and ocular manifestations in Sjögren's syndrome.
Kalk WW; Mansour K; Vissink A; Spijkervet FK; Bootsma H; Kallenberg CG; Roodenburg JL; Nieuw Amerongen AV
J Rheumatol; 2002 May; 29(5):924-30. PubMed ID: 12022351
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of labial salivary biopsy in Sjogren's syndrome: report of 182 cases].
Andretta M; Ianniello A; Ostuni PA; Siniscalchi E; Cusatelli P; Todesco S
Acta Otorhinolaryngol Ital; 1995 Feb; 15(1):40-6. PubMed ID: 7597901
[TBL] [Abstract][Full Text] [Related]
4. A comparison of salivary gland hypofunction in primary and secondary Sjögren's syndrome.
Dawson LJ; Holt DJ; Higham SM; Longman LP; Field EA
Oral Dis; 2001 Jan; 7(1):28-30. PubMed ID: 11354918
[TBL] [Abstract][Full Text] [Related]
5. The European Community Study Group on diagnostic criteria for Sjögren's syndrome. Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome.
Vitali C; Moutsopoulos HM; Bombardieri S
Ann Rheum Dis; 1994 Oct; 53(10):637-47. PubMed ID: 7979575
[TBL] [Abstract][Full Text] [Related]
6. Major salivary gland function in primary Sjögren's syndrome and its relationship to clinical features.
Atkinson JC; Travis WD; Pillemer SR; Bermudez D; Wolff A; Fox PC
J Rheumatol; 1990 Mar; 17(3):318-22. PubMed ID: 2332852
[TBL] [Abstract][Full Text] [Related]
7. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.
Meijer JM; Meiners PM; Vissink A; Spijkervet FK; Abdulahad W; Kamminga N; Brouwer E; Kallenberg CG; Bootsma H
Arthritis Rheum; 2010 Apr; 62(4):960-8. PubMed ID: 20131246
[TBL] [Abstract][Full Text] [Related]
9. Sjögren's syndrome (SS) in patients with human T cell leukemia virus I associated myelopathy: paradoxical features of the major salivary glands compared to classical SS.
Izumi M; Nakamura H; Nakamura T; Eguchi K; Nakamura T
J Rheumatol; 1999 Dec; 26(12):2609-14. PubMed ID: 10606370
[TBL] [Abstract][Full Text] [Related]
10. Sialometry and sialochemistry: a non-invasive approach for diagnosing Sjögren's syndrome.
Kalk WW; Vissink A; Stegenga B; Bootsma H; Nieuw Amerongen AV; Kallenberg CG
Ann Rheum Dis; 2002 Feb; 61(2):137-44. PubMed ID: 11796400
[TBL] [Abstract][Full Text] [Related]
11. Validity of screening tests for Sjögren's syndrome in ambulatory patients with chronic diseases.
Sánchez-Guerrero J; Pérez-Dosal MR; Celis-Aguilar E; Cárdenas-Velázquez F; Soto-Rojas AE; Avila-Casado C
J Rheumatol; 2006 May; 33(5):907-11. PubMed ID: 16541477
[TBL] [Abstract][Full Text] [Related]
12. Progression of salivary gland dysfunction in patients with Sjogren's syndrome.
Pijpe J; Kalk WW; Bootsma H; Spijkervet FK; Kallenberg CG; Vissink A
Ann Rheum Dis; 2007 Jan; 66(1):107-12. PubMed ID: 16728458
[TBL] [Abstract][Full Text] [Related]
13. Tear fluid proteins in Sjögren's syndrome.
Janssen PT; van Bijsterveld OP
Scand J Rheumatol Suppl; 1986; 61():224-7. PubMed ID: 3473637
[TBL] [Abstract][Full Text] [Related]
14. The clinical value and histopathological correlation of lacrimal scintigraphy in patients with primary Sjögren's syndrome.
Erhamamci S; Karalezli A; Yilmaz S; Aktas A
Nucl Med Commun; 2012 Jul; 33(7):689-94. PubMed ID: 22513885
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological findings consistent with primary Sjögren's syndrome in a subset of patients diagnosed with chronic fatigue syndrome: preliminary observations.
Sirois DA; Natelson B
J Rheumatol; 2001 Jan; 28(1):126-31. PubMed ID: 11196514
[TBL] [Abstract][Full Text] [Related]
16. Salivary gland parameters and clinical data related to the underlying disorder in patients with persisting xerostomia.
van den Berg I; Pijpe J; Vissink A
Eur J Oral Sci; 2007 Apr; 115(2):97-102. PubMed ID: 17451498
[TBL] [Abstract][Full Text] [Related]
17. Quantitative and visual evaluation of salivary and thyroid glands in patients with primary Sjögren's syndrome using salivary gland scintigraphy: relationship with clinicopathological features of salivary, lacrimal and thyroid glands.
Güne S; Yilmaz S; Karalezli A; Aktaş A
Nucl Med Commun; 2010 Jul; 31(7):666-72. PubMed ID: 20545046
[TBL] [Abstract][Full Text] [Related]
18. Sjögren's syndrome: correlation between histopathologic result and clinical and serologic parameters.
Giuca MR; Bonfigli D; Bartoli F; Pasini M
Minerva Stomatol; 2010 Apr; 59(4):149-54, 154-7. PubMed ID: 20360662
[TBL] [Abstract][Full Text] [Related]
19. Exocrine function in primary Sjögren syndrome: natural course and prognostic factors.
Haldorsen K; Moen K; Jacobsen H; Jonsson R; Brun JG
Ann Rheum Dis; 2008 Jul; 67(7):949-54. PubMed ID: 17962240
[TBL] [Abstract][Full Text] [Related]
20. Clinical course of primary Sjögren's syndrome: salivary, oral, and serologic aspects.
Gannot G; Lancaster HE; Fox PC
J Rheumatol; 2000 Aug; 27(8):1905-9. PubMed ID: 10955331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
